Skip to main content

Aurobindo’s Sandoz deal may face further delays

Aurobindo’s Sandoz deal may face further delays In September, Hyderabad-based Aurobindo announced that it would acquire the commercial operations of Swiss drug maker Novartis AGs’ generics unit in the US for $900 million. However, the proposed deal, which could emerge as the largest outbound deal by an Indian company, is yet to see the light of day considering that the FTC is yet to respond.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/aurobindo’s-sandoz-deal-may-face-further-delays_12818221.html
Labels:

Comments

Post a Comment

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Post a Comment
Read more

List of tax defaulters to be published from Friday: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yToJRc
Post a Comment
Read more

List of tax defaulters to be published from tomorrow: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yU0Uch
Post a Comment
Read more